Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. (Q46003090)

18 December 2017

title

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. (English)

1 reference

18 December 2017

aneurysmal subarachnoid hemorrhage

1 reference

1 reference

1 reference

7

Tom van der Poll

1 reference

18 December 2017

1

Mervyn D I Vergouwen

1 reference

18 December 2017

Janneke Horn

5

Janneke Horn

1 reference

18 December 2017

Yvo Roos

9

Yvo B W E M Roos

1 reference

18 December 2017

Bert A Coert

4

Bert A Coert

1 reference

18 December 2017

Erik Stroes

6

Erik S G Stroes

1 reference

18 December 2017

author name string

Joost C M Meijers

2

1 reference

18 December 2017

Ronald B Geskus

3

1 reference

18 December 2017

Marinus Vermeulen

8

1 reference

18 December 2017

publication date

20 May 2009

1 reference

18 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

18 December 2017

volume

29

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

1444-1453

1 reference

18 December 2017

Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Statin therapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.59

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JCBFM.2009.59

1 reference

18 December 2017

release_wmra7uq2wbgwlcgmcjokznpwj4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wmra7uq2wbgwlcgmcjokznpwj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19458605

1 reference

18 December 2017